Reported Sunday, Spyre Shows Anti-α4β7, Anti-TL1A And Anti-IL-23 Antibodies Each Efficacious In Humanized Mouse Colitis Model, With Combinations Further Improving Efficacy, At UEGW 2026
Share
Why It Matters
Spyre tested three different medicines in sick mice, and each one helped. When they used two or three together, they worked even better.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.